These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10342072)

  • 21. A flow cytometry evaluation of anti-FVIII antibodies: correlation with ELISA and Bethesda assay.
    Irigoyen MB; Primiani L; Felippo M; Candela M; Bianco RP; De Bracco MM; Galassi N
    Haemophilia; 2011 Mar; 17(2):267-74. PubMed ID: 21070488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
    Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitor development in a multitransfused patient with severe haemophilia A.
    van den Berg HM; Roosendaal G; Voorberg J; Mauser-Bunschoten EP
    Thromb Haemost; 1999 Jul; 82(1):151-2. PubMed ID: 10456472
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics.
    Kahle J; Orlowski A; Stichel D; Healey JF; Parker ET; Donfield SM; Astermark J; Berntorp E; Lollar P; Schwabe D; Königs C
    Haemophilia; 2017 Mar; 23(2):292-299. PubMed ID: 27862687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of anti-FVIII antibodies in severe haemophilia A patients with inversion of intron 22.
    Vianello F; Radossi P; Tison T; Dazzi F; Tagariello G; Davoli PG; Girolami A
    Br J Haematol; 1997 Jun; 97(4):807-9. PubMed ID: 9217180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
    Qadura M; Waters B; Burnett E; Chegeni R; Hough C; Othman M; Lillicrap D
    Haemophilia; 2011 Mar; 17(2):288-95. PubMed ID: 21091850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.
    Shetty KA; Kosloski MP; Mager DE; Balu-Iyer SV
    Biopharm Drug Dispos; 2016 Oct; 37(7):409-420. PubMed ID: 27418232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acquired haemophilia due to autoantibodies against factor VIII].
    von Depka Prondzinski M
    Hamostaseologie; 2003 Feb; 23(1):28-35. PubMed ID: 12567197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-analytical heat treatment and a FVIII ELISA improve Factor VIII antibody detection in acquired haemophilia A.
    Batty P; Platton S; Bowles L; Pasi KJ; Hart DP
    Br J Haematol; 2014 Sep; 166(6):953-6. PubMed ID: 24809434
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative measurement of FVIII inhibitors in hemophilia A patients using ELISA and the Bethesda assay.
    Kim SY; Kang SY; Lee WI
    Korean J Lab Med; 2010 Jun; 30(3):260-3. PubMed ID: 20603586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.
    Dargaud Y; Pavlova A; Lacroix-Desmazes S; Fischer K; Soucie M; Claeyssens S; Scott DW; d'Oiron R; Lavigne-Lissalde G; Kenet G; Escuriola Ettingshausen C; Borel-Derlon A; Lambert T; Pasta G; Négrier C
    Haemophilia; 2016 Jan; 22 Suppl 1(Suppl 1):1-24. PubMed ID: 26728503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
    Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
    Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization of factor VIII antibody epitopes from haemophilia A patients using cellulose bound FVIII peptide libraries].
    Albert T; Lange S; Oldenburg J; Graw J; Schramm W; Hanfland P; Brackmann HH; Schwaab R
    Hamostaseologie; 2003 Feb; 23(1):13-7. PubMed ID: 12567194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.
    Klintman J; Hillarp A; Donfield S; Berntorp E; Astermark J
    Haemophilia; 2013 Jan; 19(1):106-12. PubMed ID: 22762454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes?
    Hausammann S; Vogel M; Kremer Hovinga JA; Lacroix-Desmazes S; Stadler BM; Horn MP
    PLoS One; 2013; 8(4):e60688. PubMed ID: 23626669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of inhibitor development in severe haemophilia A children treated with cryoprecipitate and low-dose immune tolerance induction.
    ElAlfy MS; Tantawy AA; Ahmed MH; Abdin IA
    Haemophilia; 2000 Nov; 6(6):635-8. PubMed ID: 11122388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.
    Batlle J; Gómez E; Rendal E; Torea J; Lourés E; Couselo M; Vila P; Sedano C; Tusell X; Magallón M; Quintana M; González-Boullosa R; López-Fernández MF
    Ann Hematol; 1996 May; 72(5):321-6. PubMed ID: 8645745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive domain-specific analysis and immunoglobulin G profiling of anti-factor VIII antibodies using a bead-based multiplex immunoassay.
    Pezeshkpoor B; Berkemeier AC; Herbst K; Albert T; Müller J; Oldenburg J
    J Thromb Haemost; 2024 Jun; 22(6):1591-1604. PubMed ID: 38453023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.